Shuddha Suhaga

<h3> Absolute Contraindications of Shuddha Suhaga </h3> <h4> Pregnancy and planning pregnancy</h4> <ul> <li>🤰</li> <li>Recommendation: Avoid Shuddha Suhaga during pregnancy and when trying to conceive; do not self-administer it while pregnant. Consult a physician if you have taken it recently.</li> <li>Reasoning: Animal developmental studies show that boron compounds given systemically to pregnant animals caused reduced fetal growth, increased resorptions and skeletal malformations at sufficient doses; these findings are the basis for advising avoidance in pregnancy. Human data are limited but animal evidence supports a conservative approach.</li> <li>Scientific_Study_Title: The developmental toxicity of boric acid in mice, rats, and rabbits</li> <li>Scientific_Study_Authors: J J Heindel, C J Price, B A Schwetz</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/7889869/</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: In controlled studies across mice, rats and rabbits, dietary exposure to boric acid during gestation produced dose-related developmental effects: fetal weight reduction, increased resorptions, and increased incidence of skeletal malformations at higher exposure levels. Maternal toxicity (reduced weight gain, organ weight changes) accompanied higher exposures; developmental effects were observed at dose ranges that produced measurable maternal changes. These findings led the investigators to conclude that boric acid has developmental toxicity in common laboratory species and to identify exposure thresholds below which adverse effects were not observed in the study.</p> <p>This work underpins regulatory caution and is cited when recommending that boron-containing traditional preparations not be used in pregnancy because animal data show fetal/developmental harm at elevated systemic doses.</p> </li> </ul> <h4>Infants and very young children</h4> <ul> <li>🧸</li> <li>Recommendation: Do not give Shuddha Suhaga or borax-containing mixes to infants or young children; keep products containing borax out of reach.</li> <li>Reasoning: Case reports and series document seizures and toxic effects in infants after chronic or repeated oral exposure to borate/boric acid preparations - infants are far more susceptible to accumulation and toxicity.</li> <li>Scientific_Study_Title: Chronic boric acid poisoning in infants</li> <li>Scientific_Study_Authors: K O'Sullivan, M Taylor</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/6625636/</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: The authors reported a cluster of seven infants who developed seizures linked to chronic ingestion of a borax-containing honey mixture. Symptoms resolved after the mixture was stopped. The report highlights that repeated low-level ingestion in infants can produce neurologic toxicity (seizures), and that withholding the exposure led to clinical recovery. The case series demonstrates the narrow margin of safety for infants and supports guidance to avoid boron/borax exposures in this age group.</p> <p>Clinicians and toxicology centers historically caution strongly against borax/boric acid use around infants because of documented severe outcomes even with what adults might consider small amounts.</p> </li> </ul> <h4>Severe renal impairment (patients with markedly reduced kidney function)</h4> <ul> <li>🩺</li> <li>Recommendation: Avoid systemic or repeated internal use of Shuddha Suhaga in people with severe kidney disease; if exposure occurs, seek medical advice because reduced renal excretion raises toxicity risk.</li> <li>Reasoning: Boron is predominantly excreted in urine; reduced kidney function slows elimination and can increase systemic accumulation and toxicity - so renal impairment raises risk even at lower intake levels.</li> <li>Scientific_Study_Title: Toxicity of boric acid, borax and other boron containing compounds: A review</li> <li>Scientific_Study_Authors: Niels Hadrup, Marie Frederiksen, Anoop K Sharma</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33485927/</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: This recent comprehensive review summarizes human and animal data showing that boron compounds are absorbed orally and primarily eliminated in urine; intact skin is a better barrier than compromised skin for uptake. The review highlights that systemic toxicity (including renal and reproductive endpoints) results from elevated exposures and that impaired renal excretion would increase internal boron burden. The authors note reports of systemic and dermal toxicity in humans and emphasize careful exposure control for vulnerable populations; the excretion profile is a principal reason to avoid systemic use when renal clearance is impaired.</p> <p>In short, reduced kidney function materially increases the risk of boron accumulation and subsequent adverse effects.</p> </li> </ul> <h3> Relative Contraindications of Shuddha Suhaga </h3> <h4>Concurrent chemotherapy (e.g., fluoropyrimidines such as 5-fluorouracil)</h4> <ul> <li>⚠️</li> <li>Recommendation: Discuss with your oncologist before using any boron/borax preparations if you are receiving chemotherapy; avoid unsupervised self-administration.</li> <li>Reasoning: In laboratory models, borax showed potentiation of cytotoxicity when combined with 5-fluorouracil against colorectal cancer cells; while this is in vitro and not a clinical interaction proof, it suggests boron compounds can modify chemotherapy effects and warrants caution in patients on cytotoxic drugs.</li> <li>Scientific_Study_Title: Cytotoxic and Apoptotic Effects of the Combination of Borax (Sodium Tetraborate) and 5-Fluorouracil on DLD-1 Human Colorectal Adenocarcinoma Cell Line</li> <li>Scientific_Study_Authors: (as listed on the paper) [see source]</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/36047504/</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: In vitro experiments on human colorectal cancer cells (DLD-1) found that combining borax with 5-fluorouracil increased cell death and markers of apoptosis more than either agent alone; the combination produced greater nuclear condensation and fragmentation consistent with enhanced cytotoxicity. These are laboratory results (cell line) and do not directly translate to safe/unsafe clinical combinations, but they demonstrate that borax can alter drug cytotoxic profiles and merit clinician discussion when chemotherapy is planned or ongoing.</p> </li> </ul> <h4>Topical use on broken or extensively compromised skin</h4> <ul> <li>🩹</li> <li>Recommendation: Avoid applying Shuddha Suhaga/borax powders directly to large open wounds, eroded skin or mucosa without professional guidance - do not use raw borax on deep ulcers.</li> <li>Reasoning: Dermal absorption is greater through damaged skin and there are reports linking dermal exposure to severe skin reactions and systemic effects; intact skin is a better barrier but broken skin increases risk.</li> <li>Scientific_Study_Title: Toxicity of boric acid, borax and other boron containing compounds: A review</li> <li>Scientific_Study_Authors: Niels Hadrup, Marie Frederiksen, Anoop K Sharma</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33485927/</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: The authors summarize evidence that intact skin limits boron uptake but compromised skin increases absorption; several case reports and experimental data show that skin exposure over damaged surfaces can lead to local and systemic toxic effects. Because boron can be taken up transdermally when the barrier is broken, topical use on ulcers or widespread broken skin is discouraged without clinical supervision.</p> </li> </ul> <h4>Existing riboflavin (vitamin B2) deficiency or risk of vitamin depletion</h4> <ul> <li>🔋</li> <li>Recommendation: Use caution and consult a clinician when combining prolonged internal boron/borax use with patients at risk for nutritional deficiencies; consider monitoring vitamins if exposure is repeated.</li> <li>Reasoning: Clinical reports indicate boric acid ingestion increases urinary excretion of riboflavin (vitamin B2), which could exacerbate deficiency in vulnerable individuals under chronic exposure.</li> <li>Scientific_Study_Title: Increased urinary riboflavin excretion resulting from boric acid ingestion</li> <li>Scientific_Study_Authors: J Pinto, Y P Huang, R J McConnell, R S Rivlin</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/659962/</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: Analysis of patients reporting to a poison control center after boric acid ingestion showed that around two-thirds had markedly increased urinary riboflavin excretion within the first 24 hours. The authors suggest that boric acid can form complexes with the ribitol side chain of riboflavin, increasing its water solubility and urinary loss. While this is an acute-ingestion observation, it supports the idea that significant boron exposure can perturb B2 status and possibly worsen deficiency if exposures are repeated.</p> </li> </ul>